Ventas Inc. (VTR)

58.56
0.21 0.36
NYSE : Finance
Prev Close 58.77
Open 59.05
Day Low/High 58.45 / 59.07
52 Wk Low/High 56.52 / 75.40
Volume 1.81M
Avg Volume 2.06M
Exchange NYSE
Shares Outstanding 372.74M
Market Cap 21.84B
EPS 1.10
P/E Ratio 43.73
Div & Yield 3.17 (5.36%)
Ventas Announces Second Quarter 2015 Earnings Release Date And Conference Call

Ventas Announces Second Quarter 2015 Earnings Release Date And Conference Call

Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") announced today that it will issue its second quarter 2015 earnings release prior to the opening of trading on the New York Stock Exchange on Friday, July 24, 2015.

Ventas To Participate In The NAREIT REITWeek 2015 Conference

Ventas To Participate In The NAREIT REITWeek 2015 Conference

Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") announced today that management will make a presentation regarding the Company at the NAREIT REITWeek 2015 Conference in New York, New York on Wednesday, June 10, 2015,...

A Brookdale Senior Living Real Estate Spinoff Seems Inevitable

A Brookdale Senior Living Real Estate Spinoff Seems Inevitable

Activist investor Tom Sandell can't force the issue right now, but he's already lined up the assisted living company's board and its shareholder base in his favor.

Bear Chart of the Day: Ventas

Bear Chart of the Day: Ventas

I was surprised to see a health care REIT make the bearish list, but price action is what it is -- ugly.

3 Buy-Rated Dividend Stocks: VZ, VTR, CXW

3 Buy-Rated Dividend Stocks: VZ, VTR, CXW

These 3 dividend stocks are rated a Buy by TheStreet

Ventas Declares Regular Quarterly Dividend Of $0.79 Per Share

Ventas Declares Regular Quarterly Dividend Of $0.79 Per Share

Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") said today that its Board of Directors declared a regular quarterly dividend of $0.

Ventas Supports Quest To End Alzheimer's Disease

Ventas Supports Quest To End Alzheimer's Disease

Ventas, Inc. (NYSE:VTR) ("Ventas" or the "Company"), a leading real estate investment trust focused on healthcare and seniors housing, today announces its Ventas Charitable Foundation contributed $100,000 to the...

'Mad Money' Lightning Round: I'm Sticking With Cisco, Cypress Semi

'Mad Money' Lightning Round: I'm Sticking With Cisco, Cypress Semi

Cramer prefers AT&T to Vodafone and isn't recommending Teva Pharmaceuticals.

Jim Cramer's 'Mad Money' Recap: Stocks on Sale, Get'em While They're Cheap

Jim Cramer's 'Mad Money' Recap: Stocks on Sale, Get'em While They're Cheap

Investors need to stop panicking and start buying the long-term winners, Cramer says.

Ventas Reports Record 2015 First Quarter Results And Increases Guidance

Ventas Reports Record 2015 First Quarter Results And Increases Guidance

Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") today reported that normalized Funds From Operations ("FFO") for the quarter ended March 31, 2015 increased 20 percent to $387.

Trade-Ideas: Ventas (VTR) Is Today's Post-Market Leader Stock

Trade-Ideas: Ventas (VTR) Is Today's Post-Market Leader Stock

Trade-Ideas LLC identified Ventas (VTR) as a post-market leader candidate

Ventas Announces Filing Of Form 10 Registration Statement For Spin-Off Of Post-Acute / Skilled Nursing Facility Portfolio

Ventas Announces Filing Of Form 10 Registration Statement For Spin-Off Of Post-Acute / Skilled Nursing Facility Portfolio

Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") today announced the filing of an initial Form 10 Registration Statement with the Securities and Exchange Commission ("SEC") in connection with its previously announced...

Ventas Becomes #192 Most Shorted S&P 500 Component, Replacing Analog Devices

Ventas Becomes #192 Most Shorted S&P 500 Component, Replacing Analog Devices

The most recent short interest data has been released by the NASDAQ for the 03/31/2015 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

'Mad Money' Lightning Round: I Like Phillips 66, Don't Sell It

'Mad Money' Lightning Round: I Like Phillips 66, Don't Sell It

Cramer is not a big believer in Sturm Ruger, likes Kohlberg Kravis Roberts but is avoiding Emerge Energy Services.

Jim Cramer's 'Mad Money' Recap: Don't Leave Gains on the Table

Jim Cramer's 'Mad Money' Recap: Don't Leave Gains on the Table

Using traditional analysis, investors might think Netflix is ridiculously expensive compared to where shares traded just a few months or years ago. They'd be wrong, Cramer says.

Jim Cramer's Top Takeaways: Costco, Sun Edison, Ventas, Macerich

Jim Cramer's Top Takeaways: Costco, Sun Edison, Ventas, Macerich

Cramer says Costco is a quality stock while Macerich's CEO belongs on the 'Mad Money' Wall of Shame.

Jim Cramer's 'Mad Money' Recap: Ignore the Chatter, Stick With Best-of-Breed Stocks

Jim Cramer's 'Mad Money' Recap: Ignore the Chatter, Stick With Best-of-Breed Stocks

Many investors are getting caught up in the takeover speculation game, Cramer warns. Don't do it.

Ventas Announces First Quarter 2015 Earnings Release Date And Conference Call

Ventas Announces First Quarter 2015 Earnings Release Date And Conference Call

Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") announced today that it will issue its first quarter 2015 earnings release prior to the opening of trading on the New York Stock Exchange on Friday, April 24, 2015.

Enough Already About the Fed

There are much more important things going on.

Health Care REIT Ventas Plans to Purchase Welsh Carson-Backed Ardent Medical Services for $1.75B

Health Care REIT Ventas Plans to Purchase Welsh Carson-Backed Ardent Medical Services for $1.75B

Health care REIT Ventas announced an agreement to acquire private equity-backed Ardent Medical Services along with its affiliate Ardent Health Services for $1.75 billion.

Ventas (VTR) Stock Soaring Today on Ardent Health Services Acquisition

Ventas (VTR) Stock Soaring Today on Ardent Health Services Acquisition

Ventas (VTR) stock is higher after the company announced its plan to acquire the privately held Ardent Health Services.

Ventas (VTR) Highlighted As Momo Momentum Stock

Ventas (VTR) Highlighted As Momo Momentum Stock

Trade-Ideas LLC identified Ventas (VTR) as a momo momentum candidate

Ventas To Acquire Ardent Health Services For $1.75 Billion

Ventas To Acquire Ardent Health Services For $1.75 Billion

Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") announced today that it has signed a definitive agreement to acquire privately-owned Ardent Medical Services, Inc.

Ventas Announces Plan To Spin Off Post-Acute/Skilled Nursing Facility Portfolio

Ventas Announces Plan To Spin Off Post-Acute/Skilled Nursing Facility Portfolio

Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") announced today that the Company's Board of Directors has unanimously approved a plan to spin off most of its post-acute/skilled nursing facility ("SNF") portfolio into...

3 Real Estate Stocks Nudging The Industry Higher

3 Real Estate Stocks Nudging The Industry Higher

TheStreet highlights 3 stocks pushing the real estate industry higher today.

3 Real Estate Stocks Dragging The Industry Down

3 Real Estate Stocks Dragging The Industry Down

TheStreet highlights 3 stocks pushing the real estate industry lower today.

'Mad Money' Lightning Round: Buy, Buy, Buy Ventas on Any Weakness

'Mad Money' Lightning Round: Buy, Buy, Buy Ventas on Any Weakness

Cramer is no longer excited about Zulily and is avoiding Qihoo and Exelon.

Jim Cramer's 'Mad Money' Recap: Stay the Course Through This Decline

Jim Cramer's 'Mad Money' Recap: Stay the Course Through This Decline

This isn't 2008, Cramer says, so trim some positions and be ready to buy when the selling subsides.

Ventas Announces Promotions

Ventas Announces Promotions

Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") today announced the following promotions: Randy Sohanaki has been promoted to Vice President, IT Applications and he will join the Ventas Senior...

Ventas Replaces Expiring Shelf Registration Statement

Ventas Replaces Expiring Shelf Registration Statement

Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") said today that, in connection with the upcoming expiration of the Company's existing universal shelf registration statement (the "Existing Shelf Registration...

TheStreet Quant Rating: B- (Buy)